Home » Newsletters » BioWorld Science

BioWorld Science

April 18, 2006

View Archived Issues

Snapshots of histone deacetylases (HDACs) as novel effective targets in cancer therapy: Part II

New preclinical and clinical data presented on talampanel in seizures

TOP, PaTH studies reveal benefit of parathyroid hormone (1-84) in osteoporosis

PAR-101 effective against C. difficile-associated diarrhea

4SC and University of Munster collaborate on agents to target influenza

Serotonin necessary for liver regeneration

DPI and Infinity Pharmaceuticals sign definitive merger agreement

Characterization of novel dual targeting antibacterial agents from Vertex

Fast track designation for SinuNase in chronic sinusitis

Valeant to outlicense pradefovir

Series C financing at Novagali Pharma

Alnylam signs CRADA with U.S. Army on RNAi therapeutics for biodefense threats

Combination treatment studied for relapsing remitting MS

Glypromate completes phase II study in CABG patients

Japanese rimonabant rights to be transferred to sanofi-aventis

Evista offers no cardioprotection in RUTH study

Recent patents describe novel agents for cardiovascular disorders

Novel agents for hepatic disorders claimed in recent patents

Novel MRI contrast agent developed at Kyushu University

Vivitrol approved for treatment of alcohol dependence

Preclinical data presented on Aegera neuroprotectant for chemotherapy-induced neuropathy

Chugai files for Japanese approval of erlotinib in NSCLC

Vaccination with PN-277 may be useful in preventing retinal neurodegeneration

New antibacterial dianthraquinone derivatives identified

Novel antimicrobial agents demonstrate excellent in vitro activity against C. difficile

Thiazolidinedione derivative may be useful in chronic lymphocytic leukemia

A novel c-Met kinase inhibitor from Pfizer could be a potential anticancer therapy

Ecopia BioSciences presents preclinical data on its anticancer compound ECO-4601

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...